Conditions: Seasonal Allergic Rhinitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 880
Healthy volunteers: no

Brief summary:
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Watson Laboratories, Inc) with NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Detailed description:

Arms:
arm 1: Placebo arm 2: Mometasone Nasal spray arm 3: Mometasone Nasal spray

Interventions: intervention 1: placebo intervention 2: Mometasone Nasal Spray intervention 3: Mometasone nasal spray
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None

Protocol document: